Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
about
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptorMelanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interactionHuman checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cellsEpidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptorRecognition and accommodation at the androgen receptor coactivator binding interfaceModulation of Androgen Receptor Activation Function 2 by Testosterone and DihydrotestosteroneStructural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen ReceptorAn androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivationGain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen ReceptorInteraction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domainEmerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3.CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP).Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.Structural basis for computational screening of non-steroidal androgen receptor ligands.Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers.Noncanonical mechanisms to regulate nuclear receptor signaling.Estrogen receptor α/β-cofactor motif interactions; interplay of tyrosine 537/488 phosphorylation and LXXLL motifs.Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expressionMelanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.Structural features discriminate androgen receptor N/C terminal and coactivator interactions.Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and agingPost-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetryA novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin.Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain.Binding of bisphenol A, bisphenol AF, and bisphenol S on the androgen receptor: Coregulator recruitment and stimulation of potential interaction sites.Engineered repressors are potent inhibitors of androgen receptor activity.Analysis of interdomain interactions of the androgen receptor.14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.Synthesis of a tetrasubstituted tetrahydronaphthalene scaffold for α-helix mimicry via a MgBr2-catalyzed Friedel-Crafts epoxide cycloalkylation.Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL.
P2860
Q24316455-D37451FB-3729-4439-8562-0CE588EBC0C2Q24556963-1A735E76-FF62-4206-8818-473BFBA7FF5BQ24607572-30E80883-4298-4E2E-98F6-5597CE2179EFQ24652929-56D6D20A-26D5-4D13-A13B-62BC70BE6BCEQ24799399-A1454631-C15F-4519-96E9-1057F509F94BQ27646416-17AB8A18-30B8-41AA-A209-4938F13EBE4AQ27647445-CF23CA2C-3B12-48FD-BB05-B9F3754210B9Q27659041-93BCFEC2-C147-460A-999D-A34A9F9D7413Q28258333-638A6527-BDA7-4BA0-BF4D-DC8445377A93Q28288879-2DE333F5-5F47-4F78-BF8A-62DF53FCB00BQ29040033-F0BB9941-3A55-4F40-88B0-6564230E44D0Q33334030-BC655FC1-A55F-4EB1-8D5F-8CF454DE5C11Q33949697-AAB75DB2-C798-4251-A0A8-BBBDF3221069Q33967209-69AFAC98-0E53-4628-889C-3D3134D08B7CQ33967239-6AC77334-8F5C-4584-8C7B-6B82E07990F4Q33976024-AAA2DF27-E1B2-483D-92AB-3D1AB9008411Q34289773-B86CE502-CE9E-4BC9-996A-26DF9399D04EQ34313140-24C3272F-1E8F-4D7E-9B34-E5C5EBB0E8E9Q34338685-4B0EA697-B29F-4332-930B-7684C6F66E4FQ34396913-F4D44499-3C33-400C-9BB4-0014FCF757C3Q35003769-C9CA16C4-E910-41E4-98CF-F0FF7B666983Q35007914-A1A1AB74-D2BC-47D3-9EB6-93A1713CB8B1Q35062621-7599BB61-4F57-475A-B3D0-49AD84FA50B2Q35417636-7E882FFA-5AE0-46F7-92F9-4A5CD11306E3Q35793023-2B136FBC-C241-4947-AC93-1D87E5FEF40DQ36130944-5EB406EB-7B17-41C3-831B-AEEF3AAA74B8Q36139948-407EC445-4CEC-47C4-B076-E242A2C144E5Q36237251-41636A26-AB06-42D4-B388-5F2DEBC2E4CBQ36841870-4AA6F040-8BF4-438F-A5C4-BE96EF38987DQ37210787-502B7048-21FA-4319-85E6-DBFFD024C464Q37283611-6E9C2FB3-C4F5-45A0-BD8F-5C41A15DA189Q38656709-FB2E5118-DCAD-40D1-A8F2-874899025287Q39012681-C976CF67-09F5-424D-9E2B-7B7AC4FB0430Q39499483-0A580AF0-4C40-416B-9A8F-BE276C7DAA4CQ39765541-78E3BBD9-C55B-4E54-990D-D08145272F82Q40609407-9E664E6A-8D66-4D08-8A72-279A6A58E025Q42062610-368F88BD-2FDA-4EB6-A5A6-1F1FC48C3638Q43239840-9F05E4FA-7242-4DA9-B65C-A70E72C2DB87Q44922990-DC62416A-BFDD-40FA-B9A5-3A342C2372CF
P2860
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@ast
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@en
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@nl
type
label
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@ast
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@en
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@nl
prefLabel
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@ast
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@en
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@nl
P2860
P1476
Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs
@en
P2093
Elizabeth M Wilson
P2860
P304
P356
10.1128/MCB.23.6.2135-2150.2003
P407
P577
2003-03-01T00:00:00Z